OneMedNet Corp 8-K, filed Nov 22, 2023
OneMedNet Corp (ONMD)
About this 8-K
OneMedNet Corp filed this 8-K on November 22, 2023, reporting on events of November 20, 2023.
Items reported
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant
to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State
or other jurisdiction of incorporation) |
(Commission
File Number) |
(I.R.S.
Employer Identification Number) |
(Address of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code:
Data Knights Acquisition Corp.
Unit G6, Frome Business Park, Manor Road
Frome, United Kingdom, BA11 4FN
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Trading
Symbol(s) |
Name
of Each Exchange on Which Registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 7.01 Regulation FD Disclosure.
On October 20, 2023, OneMedNet Corporation (the “Company”) issued a press release to announce its Technical Exhibit during the Radiological Society of North America’s (“RSNA”) 2023 Annual Meeting from November 26 - 30, 2023 at McCormick Place in Chicago. The press release is attached hereto as Exhibit 99.1 and incorporated herein by this reference.
The information contained in the press release attached hereto is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that Section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. | Description | |
| 99.1 | Press Release dated November 20, 2023 | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ONEMEDNET CORPORATION | ||
| Date: November 22, 2023 | ||
| By: | /s/ Paul J. Casey | |
| Name: | Paul J. Casey | |
| Title: | Chief Executive Officer | |
Exhibit 99.1
OneMedNet Announces Participation as an Exhibitor in the AI Showcase During the RSNA 2023 Annual Meeting
Minneapolis, MN – November 20, 2023, OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet”), the leading curator of regulatory-grade imaging Real World Data (“RWD”), today announced its Technical Exhibit during the Radiological Society of North America’s (“RSNA”) 2023 Annual Meeting from November 26 - 30, 2023 at McCormick Place in Chicago. OneMedNet’s senior team will be on-site to display OneMedNet’s iRWD™ solution via the Artificial Intelligence (“AI”) Showcase in the South Hall A, Level 3, Exhibit Booth #4669. To learn more about OneMedNet and their Real World Data Capabilities, please visit www.onemednet.com.
The 2023 RSNA Meeting, titled “RSNA 2023: Leading Through Change” is the largest radiology conference in the U.S. and features the latest in CT, MRI, AI, 3D printing and other imaging modalities. OneMedNet’s iRWD™ solution aggregates clinical imaging data and, through the use of advanced technology, securely anonymizes images to provide its network partners with the foundation to advance research and development protocols and diagnostics in the life sciences field.
About the RSNA Annual Meeting
RSNA promotes excellence in patient care and health care delivery through education, research and technologic innovation. RSNA is the world’s leading professional radiology organization providing the expertise, practical use and distinct tools needed for the ethical application of AI technology in medical imaging, which aligns with OneMedNet’s unwavering clinical imaging practice and its iRWD™ solution. RSNA 2023 will connect the international radiology community of medical technology professionals, clinicians, students and its diverse attendee participation by providing the latest in AI research, education and technological advances. See 2023 RSNA Meeting and registration information at www.rsna.org.
About OneMedNet Corporation
OneMedNet was the first company to trademark a RWD offering through its OneMedNet iRWD™ solution that utilizes AI to securely de-identify, search, and curate imaging data for the benefit of its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet integrates AI and other digital technologies into their existing development processes to enhance data anomaly detection, standardization, and quality checking at the pre-processing stage. AI offers OneMedNet’s partners and customers the ability to increase meaningful Real World Evidence output, decrease time to insights, and make the most of the available vast data sources.
The OneMedNet iRWD network consists of more than 200 healthcare systems and providers. Founded in 2009, OneMedNet provides innovative solutions that unlock the significant value contained within the clinical image archives of healthcare providers. Employing its proven OneMedNet iRWD™ solution, OneMedNet securely de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with industry leading technology and in-house clinical expertise, OneMedNet successfully meets the most rigorous RWD Life Science requirements. For more information, please visit www.onemednet.com.
Investor Contact:
Shannon Devine
MZ Group North America
203-741-8811
ONMD@mzgroup.us
Source: OneMedNet